[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Stiripentol.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be decreased when combined with Stiripentol.]
[J01GA01, streptomycin, Stiripentol may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Stiripentol.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01CG01, sulbactam, Stiripentol may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The metabolism of Sulfadiazine can be decreased when combined with Stiripentol.]
[J01EC01, sulfamethoxazole, The metabolism of Sulfamethoxazole can be decreased when combined with Stiripentol.]
[M04AB02, sulfinpyrazone, The metabolism of Sulfinpyrazone can be decreased when combined with Stiripentol.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Sulpiride is combined with Stiripentol.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Sulthiame is combined with Stiripentol.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Stiripentol.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01BB02, mercaptopurine, Stiripentol may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DA01, tacrine, The metabolism of Tacrine can be increased when combined with Stiripentol.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Stiripentol.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Stiripentol.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Stiripentol.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Stiripentol.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Stiripentol.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Stiripentol.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Tetracycline can be decreased when combined with Stiripentol.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05AE05, lurasidone, The metabolism of Lurasidone can be decreased when combined with Stiripentol.]
[A04AD10, dronabinol, The metabolism of Dronabinol can be decreased when combined with Stiripentol.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Stiripentol.]
[L04AX02, thalidomide, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, Stiripentol may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Stiripentol.]
[P02CA02, thiabendazole, The metabolism of Thiabendazole can be increased when combined with Stiripentol.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Stiripentol.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Stiripentol.]
[N05CA19, thiopental, The metabolism of Thiopental can be decreased when combined with Stiripentol.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Thioproperazine is combined with Stiripentol.]
[N05AC02, thioridazine, The metabolism of Thioridazine can be decreased when combined with Stiripentol.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Stiripentol.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Stiripentol.]
[G04BE06, moxisylyte, Stiripentol may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Stiripentol is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Stiripentol.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Tilidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Stiripentol.]
[P01AB02, tinidazole, The metabolism of Tinidazole can be decreased when combined with Stiripentol.]
[S01AA12, tobramycin, Stiripentol may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Stiripentol.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Stiripentol.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Tolperisone is combined with Stiripentol.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Stiripentol.]
[N06AF04, tranylcypromine, The metabolism of Tranylcypromine can be decreased when combined with Stiripentol.]
[N06AX05, trazodone, The serum concentration of Trazodone can be increased when it is combined with Stiripentol.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Stiripentol.]
[S01BA05, triamcinolone, The metabolism of Triamcinolone can be decreased when combined with Stiripentol.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Stiripentol.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AB12, mepenzolate, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[A16AX12, trientine, Triethylenetetramine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Stiripentol.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Stiripentol is combined with Trifluperidol.]
[N05AA05, triflupromazine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[S01BA09, clobetasone, The metabolism of Clobetasone can be decreased when combined with Stiripentol.]
[S01BA10, alclometasone, The metabolism of Alclometasone can be decreased when combined with Stiripentol.]
[N04AA01, trihexyphenidyl, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The metabolism of Mometasone can be decreased when combined with Stiripentol.]
[A03AA05, trimebutine, The metabolism of Trimebutine can be decreased when combined with Stiripentol.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Alimemazine is combined with Stiripentol.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Stiripentol.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be decreased when combined with Stiripentol.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Stiripentol.]
[R06AC04, tripelennamine, The metabolism of Tripelennamine can be decreased when combined with Stiripentol.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Stiripentol.]
[A03BB01, butylscopolamine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Troleandomycin can be decreased when combined with Stiripentol.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Stiripentol.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Stiripentol.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Tubocurarine is combined with Stiripentol.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Stiripentol.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Stiripentol.]
[R02AA14, oxyquinoline, Stiripentol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Abiraterone can be decreased when combined with Stiripentol.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be decreased when combined with Stiripentol.]
[J05AP03, boceprevir, The metabolism of Boceprevir can be decreased when combined with Stiripentol.]
[J05AP02, telaprevir, The metabolism of Telaprevir can be decreased when combined with Stiripentol.]
[J05AG05, rilpivirine, The metabolism of Rilpivirine can be decreased when combined with Stiripentol.]
[S01AA28, vancomycin, Stiripentol may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Ezogabine is combined with Stiripentol.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Stiripentol.]
[R03AC18, indacaterol, The metabolism of Indacaterol can be decreased when combined with Stiripentol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Stiripentol.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Stiripentol.]
[N06AX09, viloxazine, The metabolism of Stiripentol can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Stiripentol.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Stiripentol.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Stiripentol.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A11HA03, vitamin E, The metabolism of Vitamin E can be decreased when combined with Stiripentol.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Stiripentol.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The metabolism of Zidovudine can be decreased when combined with Stiripentol.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Stiripentol.]
[J05AE02, indinavir, The metabolism of Indinavir can be decreased when combined with Stiripentol.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Levetiracetam is combined with Stiripentol.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Stiripentol.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Stiripentol.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Stiripentol.]
[R03DC01, zafirlukast, The metabolism of Stiripentol can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Rabeprazole can be decreased when combined with Stiripentol.]
[J01MA13, trovafloxacin, The metabolism of Stiripentol can be decreased when combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Stiripentol is combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Stiripentol.]
[V03AC02, deferiprone, Deferiprone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Stiripentol.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Stiripentol.]
[G04BD07, tolterodine, The serum concentration of Tolterodine can be increased when it is combined with Stiripentol.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Stiripentol.]
[L03AB11, peginterferon alfa-2a, The metabolism of Stiripentol can be decreased when combined with Peginterferon alfa-2a.]
[J02AC03, voriconazole, The metabolism of Voriconazole can be decreased when combined with Stiripentol.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Stiripentol is combined with Atracurium.]
[S01FA01, atropine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Stiripentol.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Stiripentol.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Stiripentol.]
[H02AB11, prednylidene, The metabolism of Prednylidene can be decreased when combined with Stiripentol.]
[B03XA04, peginesatide, Peginesatide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be increased when combined with Stiripentol.]
[L01BC05, gemcitabine, The excretion of Gemcitabine can be decreased when combined with Stiripentol.]
[J01CA09, azlocillin, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Azlocillin.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Stiripentol.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Stiripentol.]
[G04BD12, mirabegron, The metabolism of Mirabegron can be decreased when combined with Stiripentol.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be increased when it is combined with Stiripentol.]
[V03AX03, cobicistat, The metabolism of Cobicistat can be decreased when combined with Stiripentol.]
[J05AJ02, elvitegravir, The metabolism of Elvitegravir can be decreased when combined with Stiripentol.]
[L02BB04, enzalutamide, The metabolism of Enzalutamide can be decreased when combined with Stiripentol.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Stiripentol.]
[L04AA31, teriflunomide, The excretion of Teriflunomide can be decreased when combined with Stiripentol.]
[H02AA01, aldosterone, The metabolism of Aldosterone can be decreased when combined with Stiripentol.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Stiripentol.]
[N05CA04, barbital, The metabolism of Barbital can be decreased when combined with Stiripentol.]
[D02BA02, octinoxate, Stiripentol may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Nelfinavir can be decreased when combined with Stiripentol.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Stiripentol.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Rasagiline is combined with Stiripentol.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be decreased when combined with Stiripentol.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Stiripentol is combined with Mosapride.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Stiripentol.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Stiripentol.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Stiripentol.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Stiripentol.]
[R06AC06, thonzylamine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Stiripentol.]
[V09IX04, fluorodeoxyglucose F18, Stiripentol may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Stiripentol is combined with Diethyl ether.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Stiripentol.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Stiripentol.]
[V08CA11, gadofosveset, Gadofosveset trisodium may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Stiripentol.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Stiripentol.]
[A16AX08, teduglutide, Teduglutide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Stiripentol.]
[J04AK05, bedaquiline, The metabolism of Bedaquiline can be decreased when combined with Stiripentol.]
[C04AX11, bencyclane, The metabolism of Bencyclane can be decreased when combined with Stiripentol.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Stiripentol.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Glycerol phenylbutyrate can be decreased when combined with Stiripentol.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Stiripentol.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Stiripentol.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Stiripentol is combined with Benperidol.]
[A10BK02, canagliflozin, The metabolism of Canagliflozin can be decreased when combined with Stiripentol.]
[J01MA15, gemifloxacin, The metabolism of Stiripentol can be decreased when combined with Gemifloxacin.]
[M04AB03, benzbromarone, The metabolism of Stiripentol can be decreased when combined with Benzbromarone.]
[S01AE07, moxifloxacin, The metabolism of Stiripentol can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The excretion of Tegaserod can be decreased when combined with Stiripentol.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Stiripentol.]
[L03AA12, ancestim, Ancestim may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Stiripentol.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Naratriptan is combined with Stiripentol.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Stiripentol.]
[N04AC01, benztropine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The metabolism of Dabrafenib can be decreased when combined with Stiripentol.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EE01, trametinib, Trametinib may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Stiripentol.]
[V09AX05, florbetapir F-18, Stiripentol may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, The excretion of Afatinib can be decreased when combined with Stiripentol.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Stiripentol.]
[J05AJ03, dolutegravir, The excretion of Dolutegravir can be decreased when combined with Stiripentol.]
[C08EA02, bepridil, The metabolism of Bepridil can be decreased when combined with Stiripentol.]
[C02KX05, riociguat, The serum concentration of Riociguat can be increased when it is combined with Stiripentol.]
[A10BJ03, lixisenatide, Stiripentol may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, The metabolism of Macitentan can be decreased when combined with Stiripentol.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Stiripentol.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Stiripentol.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be decreased when combined with Stiripentol.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Eslicarbazepine.]
[D01AC18, luliconazole, The serum concentration of Stiripentol can be increased when it is combined with Luliconazole.]
[J05AP05, simeprevir, The metabolism of Simeprevir can be decreased when combined with Stiripentol.]
[J05AP08, sofosbuvir, The excretion of Sofosbuvir can be decreased when combined with Stiripentol.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Vigabatrin is combined with Stiripentol.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Stiripentol.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C07AB04, acebutolol, The metabolism of Acebutolol can be decreased when combined with Stiripentol.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Stiripentol.]
[A16AA07, metreleptin, The metabolism of Stiripentol can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Apremilast can be decreased when combined with Stiripentol.]
[L02BG02, formestane, Formestane may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S03BA03, betamethasone, The metabolism of Betamethasone can be decreased when combined with Stiripentol.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Stiripentol.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C10AB02, bezafibrate, The metabolism of Bezafibrate can be decreased when combined with Stiripentol.]
[L04AC11, siltuximab, The metabolism of Stiripentol can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Stiripentol.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Stiripentol.]
[A03BA03, hyoscyamine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Stiripentol.]
[L01XH04, belinostat, The excretion of Belinostat can be decreased when combined with Stiripentol.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Stiripentol.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Stiripentol is combined with Alfaxalone.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Stiripentol.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[D11AA01, glycopyrronium, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05CM19, suvorexant, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Stiripentol.]
[J01XA05, oritavancin, The metabolism of Oritavancin can be decreased when combined with Stiripentol.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Acepromazine is combined with Stiripentol.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Stiripentol.]
[N04AA02, biperiden, The metabolism of Biperiden can be decreased when combined with Stiripentol.]
[A11HA08, tocophersolan, The metabolism of Tocofersolan can be decreased when combined with Stiripentol.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Stiripentol.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Stiripentol.]
[S03AA06, gentamicin, Stiripentol may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Stiripentol.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Stiripentol.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Stiripentol.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Stiripentol.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Stiripentol.]
[L04AC10, secukinumab, The metabolism of Stiripentol can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Stiripentol.]
[L01EX08, lenvatinib, The excretion of Lenvatinib can be decreased when combined with Stiripentol.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Stiripentol.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Stiripentol.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Stiripentol.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A03AA09, difemerine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[C01EB17, ivabradine, The metabolism of Ivabradine can be decreased when combined with Stiripentol.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Stiripentol.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Stiripentol.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Stiripentol.]
[A04AD14, rolapitant, The metabolism of Rolapitant can be decreased when combined with Stiripentol.]
[G02CX02, flibanserin, The metabolism of Flibanserin can be decreased when combined with Stiripentol.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be decreased when combined with Stiripentol.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Acetazolamide is combined with Stiripentol.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Acetophenazine is combined with Stiripentol.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Stiripentol.]
[V03AB37, idarucizumab, Stiripentol may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Stiripentol.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Stiripentol.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Stiripentol.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Stiripentol.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Stiripentol.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Stiripentol.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Stiripentol.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Stiripentol.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Stiripentol.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Stiripentol.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Stiripentol.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Stiripentol.]
[J05AP11, grazoprevir, The metabolism of Grazoprevir can be decreased when combined with Stiripentol.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Aprobarbital is combined with Stiripentol.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Stiripentol.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Stiripentol.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Bromazepam is combined with Stiripentol.]
[N04BC01, bromocriptine, The metabolism of Bromocriptine can be decreased when combined with Stiripentol.]
[A02AD05, aluminum magnesium silicate, Stiripentol may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Alverine is combined with Stiripentol.]
[D07AC11, amcinonide, The metabolism of Amcinonide can be decreased when combined with Stiripentol.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Stiripentol.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Amineptine is combined with Stiripentol.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be decreased when combined with Stiripentol.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Stiripentol.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Aniracetam is combined with Stiripentol.]
[A05AA04, obeticholic acid, The metabolism of Stiripentol can be decreased when combined with Obeticholic acid.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Stiripentol.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Stiripentol.]
[N07BC01, buprenorphine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Stiripentol.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Stiripentol.]
[L01XX27, arsenic trioxide, Arsenic trioxide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Stiripentol.]
[M02AA03, clofezone, The metabolism of Rabeprazole can be decreased when combined with Stiripentol.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Butorphanol is combined with Stiripentol.]
[R06AX09, azatadine, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Azatadine.]
[S01GX07, azelastine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be decreased when combined with Stiripentol.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Stiripentol.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Stiripentol.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R03DA08, bamifylline, Stiripentol may increase the excretion rate of Bamifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AH05, naldemedine, Stiripentol may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Stiripentol.]
[N02BF02, pregabalin, The therapeutic efficacy of Stiripentol can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Beclamide is combined with Stiripentol.]
[N06BC01, caffeine, The metabolism of Stiripentol can be decreased when combined with Caffeine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Calcitriol can be decreased when combined with Stiripentol.]
[P01CA02, benznidazole, Stiripentol may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Linezolid.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Tipranavir can be decreased when combined with Stiripentol.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Stiripentol.]
[L04AB02, infliximab, The metabolism of Stiripentol can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Stiripentol.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Stiripentol.]
[N04BD03, safinamide, The metabolism of Safinamide can be decreased when combined with Stiripentol.]
[J01MA23, delafloxacin, The excretion of Delafloxacin can be decreased when combined with Stiripentol.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Stiripentol.]
[P03AC02, bioallethrin, The metabolism of Bioallethrin can be decreased when combined with Stiripentol.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Stiripentol.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Stiripentol.]
[L01EH02, neratinib, The serum concentration of Neratinib can be increased when it is combined with Stiripentol.]
[L01FB01, inotuzumab ozogamicin, The excretion of Inotuzumab ozogamicin can be decreased when combined with Stiripentol.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Stiripentol.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Stiripentol.]
[C07AB07, bisoprolol, The metabolism of Bisoprolol can be decreased when combined with Stiripentol.]
[S01EC04, brinzolamide, The metabolism of Brinzolamide can be decreased when combined with Stiripentol.]
[J05AG03, efavirenz, The metabolism of Efavirenz can be decreased when combined with Stiripentol.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Stiripentol.]
[N04AA11, bornaprine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Stiripentol is combined with Bromperidol.]
[N05CD09, brotizolam, The metabolism of Brotizolam can be decreased when combined with Stiripentol.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Budesonide can be decreased when combined with Stiripentol.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Stiripentol.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Butobarbital is combined with Stiripentol.]
[J05AX18, letermovir, The metabolism of Stiripentol can be increased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Butriptyline is combined with Stiripentol.]
[C01AA02, acetyldigoxins, Stiripentol may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Capsaicin.]
[A10BK04, ertugliflozin, The excretion of Ertugliflozin can be decreased when combined with Stiripentol.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Stiripentol is combined with Vinylbital.]
[R06AX18, acrivastine, Stiripentol may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[V04CD06, macimorelin, The metabolism of Macimorelin can be decreased when combined with Stiripentol.]
[L02BB05, apalutamide, The metabolism of Apalutamide can be decreased when combined with Stiripentol.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Stiripentol.]
[A03AA03, camylofine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Stiripentol.]
[L03AB06, interferon alfa-n1, The metabolism of Stiripentol can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Stiripentol.]
[B02BX09, fostamatinib, The metabolism of Fostamatinib can be decreased when combined with Stiripentol.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Stiripentol.]
[B02BX08, avatrombopag, The excretion of Avatrombopag can be decreased when combined with Stiripentol.]
[L04AA37, baricitinib, The metabolism of Baricitinib can be decreased when combined with Stiripentol.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Stiripentol.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Stiripentol.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01GB14, plazomicin, Stiripentol may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Stiripentol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Stiripentol.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Stiripentol.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Stiripentol.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be decreased when combined with Stiripentol.]
[J01MB04, pipemidic acid, The metabolism of Stiripentol can be decreased when combined with Pipemidic acid.]
[B02BX07, lusutrombopag, The excretion of Lusutrombopag can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Stiripentol can be decreased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Stiripentol.]
[J01AA13, eravacycline, The metabolism of Eravacycline can be decreased when combined with Stiripentol.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Stiripentol.]
[J01AA15, omadacycline, The excretion of Omadacycline can be decreased when combined with Stiripentol.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Stiripentol.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Stiripentol is combined with Carbromal.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Stiripentol.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Stiripentol may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Stiripentol.]
[R03DA02, oxtriphylline, Stiripentol may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01XK04, talazoparib, The excretion of Talazoparib can be decreased when combined with Stiripentol.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Stiripentol.]
[R03BB08, revefenacin, The excretion of Revefenacin can be decreased when combined with Stiripentol.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Stiripentol.]
[L04AA39, emapalumab, The metabolism of Stiripentol can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Carmustine can be increased when combined with Stiripentol.]
[L01EX12, larotrectinib, The metabolism of Larotrectinib can be decreased when combined with Stiripentol.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Stiripentol.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Stiripentol.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Stiripentol.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Stiripentol.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Cinitapride is combined with Stiripentol.]
[P02BX04, triclabendazole, The metabolism of Stiripentol can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Esketamine.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Stiripentol is combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Clarithromycin can be decreased when combined with Stiripentol.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Stiripentol is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Stiripentol is combined with Brexanolone.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Stiripentol.]
[N05BA09, clobazam, The metabolism of Clobazam can be decreased when combined with Stiripentol.]
[H02AB14, cloprednol, The metabolism of Cloprednol can be decreased when combined with Stiripentol.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Cloxazolam is combined with Stiripentol.]
[C09CA06, candesartan, The metabolism of Candesartan can be decreased when combined with Stiripentol.]
[L04AB01, etanercept, The metabolism of Stiripentol can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Cortivazol can be decreased when combined with Stiripentol.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Stiripentol.]
[L01FX14, polatuzumab vedotin, The risk or severity of adverse effects can be increased when Stiripentol is combined with Polatuzumab vedotin.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01XX66, selinexor, The metabolism of Selinexor can be decreased when combined with Stiripentol.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be increased when it is combined with Stiripentol.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Stiripentol.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DD01, cefotaxime, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Cefotaxime.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Cyamemazine is combined with Stiripentol.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Stiripentol.]
[L04AA44, upadacitinib, The metabolism of Upadacitinib can be decreased when combined with Stiripentol.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Stiripentol.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Stiripentol.]
[N07XX11, pitolisant, The serum concentration of Stiripentol can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The serum concentration of Pretomanid can be increased when it is combined with Stiripentol.]
[J01XX12, lefamulin, The serum concentration of Lefamulin can be increased when it is combined with Stiripentol.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Stiripentol.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Stiripentol.]
[A10AE03, insulin, regular, pork, The metabolism of Stiripentol can be increased when combined with Insulin pork.]
[J01XX09, daptomycin, The excretion of Daptomycin can be decreased when combined with Stiripentol.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Stiripentol.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DB03, cephalothin, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Cefalotin.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be increased when it is combined with Stiripentol.]
[G03DB05, demegestone, The metabolism of Demegestone can be decreased when combined with Stiripentol.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Stiripentol.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Stiripentol.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Stiripentol.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Stiripentol.]
[N03AX25, cenobamate, The serum concentration of Stiripentol can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Stiripentol can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Stiripentol may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Stiripentol.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Stiripentol.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Stiripentol.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Stiripentol.]
[S01XA12, dexpanthenol, Stiripentol may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Dezocine is combined with Stiripentol.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Stiripentol.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Stiripentol.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Stiripentol.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be increased when it is combined with Stiripentol.]
[M01AX21, diacetylrhein, The metabolism of Diacerein can be decreased when combined with Stiripentol.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be decreased when combined with Stiripentol.]
[J05AB16, remdesivir, The metabolism of Remdesivir can be decreased when combined with Stiripentol.]
[S01AE06, gatifloxacin, The metabolism of Stiripentol can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The serum concentration of Osilodrostat can be increased when it is combined with Stiripentol.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Stiripentol.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Frovatriptan is combined with Stiripentol.]
[L04AA38, ozanimod, Stiripentol may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Stiripentol.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Stiripentol.]
[R02AA03, dichlorobenzyl alcohol, Stiripentol may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, The metabolism of Dienogest can be decreased when combined with Stiripentol.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Difenoxin is combined with Stiripentol.]
[D07AC19, difluprednate, The metabolism of Difluprednate can be decreased when combined with Stiripentol.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Stiripentol.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Stiripentol.]
[M01AH02, rofecoxib, The metabolism of Rofecoxib can be decreased when combined with Stiripentol.]
[L01XF03, bexarotene, The metabolism of Bexarotene can be decreased when combined with Stiripentol.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Stiripentol.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Stiripentol.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Valpromide is combined with Stiripentol.]
[L01AA02, chlorambucil, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Chlorambucil.]
[S03AA08, chloramphenicol, The metabolism of Stiripentol can be decreased when combined with Chloramphenicol.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Stiripentol.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be decreased when combined with Stiripentol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Stiripentol.]
[A03AA08, dihexyverine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be increased when it is combined with Stiripentol.]
[D07XB03, fluprednidene, The metabolism of Fluprednidene can be decreased when combined with Stiripentol.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be decreased when combined with Stiripentol.]
[G04BD09, trospium, The metabolism of Trospium can be decreased when combined with Stiripentol.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be increased when it is combined with Stiripentol.]
[V08CA05, mangafodipir, Mangafodipir may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be increased when it is combined with Stiripentol.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Stiripentol.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Chlormezanone is combined with Stiripentol.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Dyclonine.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be increased when it is combined with Stiripentol.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Stiripentol.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Stiripentol.]
[J05AX29, fostemsavir, The metabolism of Fostemsavir can be decreased when combined with Stiripentol.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Stiripentol.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Stiripentol is combined with Remimazolam.]
[N07XX04, sodium oxybate, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L01FX15, belantamab mafodotin, The excretion of Belantamab mafodotin can be decreased when combined with Stiripentol.]
[L04AC19, satralizumab, The serum concentration of Stiripentol can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Stiripentol is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Stiripentol.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Stiripentol.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Stiripentol.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Stiripentol.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Stiripentol.]
[N05AF03, chlorprothixene, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Stiripentol.]
[A11CC05, cholecalciferol, The metabolism of Cholecalciferol can be decreased when combined with Stiripentol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Etifoxine is combined with Stiripentol.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N02BA03, choline salicylate, Stiripentol may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, The metabolism of Vinpocetine can be decreased when combined with Stiripentol.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Stiripentol.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be decreased when combined with Stiripentol.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Stiripentol.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Stiripentol.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Stiripentol.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Stiripentol.]
[M01AX25, chondroitin sulfates, Stiripentol may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be decreased when combined with Stiripentol.]
[P03AX07, abametapir, The serum concentration of Stiripentol can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Stiripentol.]
[V03AF12, trilaciclib, The excretion of Trilaciclib can be decreased when combined with Stiripentol.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Stiripentol is combined with Febarbamate.]
[N03AX10, felbamate, The metabolism of Felbamate can be decreased when combined with Stiripentol.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N06BA10, fenethylline, Stiripentol may increase the excretion rate of Fenethylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Stiripentol.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01MB07, flumequine, The metabolism of Stiripentol can be decreased when combined with Flumequine.]
[R03BA03, flunisolide, The metabolism of Flunisolide can be decreased when combined with Stiripentol.]
[S02BA08, fluocinolone acetonide, The metabolism of Fluocinolone acetonide can be decreased when combined with Stiripentol.]
[N02BG07, flupirtine, Flupirtine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Stiripentol.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Stiripentol.]
[L01EK03, tivozanib, The excretion of Tivozanib can be decreased when combined with Stiripentol.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Stiripentol is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Peginterferon alfa-2b can be decreased when combined with Stiripentol.]
[L01FX22, loncastuximab tesirine, The excretion of Loncastuximab tesirine can be decreased when combined with Stiripentol.]
[A02BA01, cimetidine, The metabolism of Cimetidine can be decreased when combined with Stiripentol.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Gabapentin is combined with Stiripentol.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Stiripentol.]
[J01MB06, cinoxacin, The metabolism of Stiripentol can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Stiripentol can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Stiripentol.]
[S03AA07, ciprofloxacin, The metabolism of Stiripentol can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Stiripentol may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The serum concentration of Citalopram can be increased when it is combined with Stiripentol.]
[H01AC07, somapacitan, The metabolism of Stiripentol can be decreased when combined with Somapacitan.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be increased when it is combined with Stiripentol.]
[C03DA05, finerenone, The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Stiripentol.]
[L04AA48, belumosudil, The metabolism of Belumosudil can be decreased when combined with Stiripentol.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Stiripentol.]
[L01XX74, belzutifan, The serum concentration of Belzutifan can be increased when it is combined with Stiripentol.]
[H01AC09, lonapegsomatropin, The metabolism of Stiripentol can be increased when combined with Lonapegsomatropin.]
[L01EB10, mobocertinib, The serum concentration of Mobocertinib can be increased when it is combined with Stiripentol.]
[L01FX23, tisotumab vedotin, The metabolism of Tisotumab vedotin can be decreased when combined with Stiripentol.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Stiripentol.]
[L04AA59, avacopan, The metabolism of Avacopan can be decreased when combined with Stiripentol.]
[R06AA04, clemastine, The metabolism of Clemastine can be decreased when combined with Stiripentol.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be increased when combined with Stiripentol.]
[A10BB12, glimepiride, The metabolism of Glimepiride can be decreased when combined with Stiripentol.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Stiripentol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Stiripentol.]
[N06AX25, St. John's wort extract, The metabolism of St. John's Wort can be decreased when combined with Stiripentol.]
[L01EA06, asciminib, The serum concentration of Asciminib can be increased when it is combined with Stiripentol.]
[L02BG06, exemestane, The metabolism of Exemestane can be decreased when combined with Stiripentol.]
[J05AX10, maribavir, The metabolism of Maribavir can be decreased when combined with Stiripentol.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Stiripentol.]
[D07AD01, clobetasol, The metabolism of Clobetasol can be decreased when combined with Stiripentol.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Stiripentol.]
[C10AB01, clofibrate, The metabolism of Clofibrate can be decreased when combined with Stiripentol.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be decreased when combined with Stiripentol.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Stiripentol.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be increased when it is combined with Stiripentol.]
[G03GB02, clomiphene, The excretion of Clomifene can be decreased when combined with Stiripentol.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Stiripentol.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be decreased when combined with Stiripentol.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Stiripentol.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Stiripentol.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Stiripentol.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Clothiapine.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be decreased when combined with Stiripentol.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Stiripentol.]
[A04AA02, granisetron, The metabolism of Granisetron can be decreased when combined with Stiripentol.]
[L01XX77, adagrasib, The serum concentration of Adagrasib can be increased when it is combined with Stiripentol.]
[N05AH02, clozapine, The metabolism of Clozapine can be decreased when combined with Stiripentol.]
[L01EN04, futibatinib, The metabolism of Futibatinib can be decreased when combined with Stiripentol.]
[J01GB12, arbekacin, Stiripentol may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Halazepam is combined with Stiripentol.]
[H01AC08, somatrogon, The metabolism of Stiripentol can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The metabolism of Cocaine can be decreased when combined with Stiripentol.]
[M09AX11, palovarotene, The serum concentration of Palovarotene can be increased when it is combined with Stiripentol.]
[C02KB01, metyrosine, Stiripentol may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Stiripentol can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R05DA04, codeine, The metabolism of Codeine can be decreased when combined with Stiripentol.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Hexafluronium is combined with Stiripentol.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Stiripentol.]
[A03AB10, hexocyclium, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[J01XB01, colistin, Stiripentol may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L04AA13, leflunomide, The excretion of Leflunomide can be decreased when combined with Stiripentol.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Desflurane is combined with Stiripentol.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Stiripentol is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Ifenprodil is combined with Stiripentol.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Stiripentol.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01FA15, telithromycin, The metabolism of Telithromycin can be decreased when combined with Stiripentol.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Stiripentol.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Desloratadine is combined with Stiripentol.]
[J05AB14, valganciclovir, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Valganciclovir.]
[C05BB03, invert sugar, Stiripentol may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[V08AB05, iopromide, Stiripentol may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Stiripentol may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Stiripentol may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be decreased when combined with Stiripentol.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Stiripentol.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Stiripentol.]
[J02AC02, itraconazole, The metabolism of Itraconazole can be decreased when combined with Stiripentol.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be increased when combined with Stiripentol.]
[N05BA10, ketazolam, The metabolism of Ketazolam can be decreased when combined with Stiripentol.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Imatinib can be increased when it is combined with Stiripentol.]
[J02AC04, posaconazole, The metabolism of Posaconazole can be decreased when combined with Stiripentol.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be decreased when combined with Stiripentol.]
[C08CA09, lacidipine, The metabolism of Lacidipine can be decreased when combined with Stiripentol.]
[N03AX09, lamotrigine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[S01BA03, cortisone, The metabolism of Cortisone can be decreased when combined with Stiripentol.]
[N07BC04, lofexidine, The therapeutic efficacy of Stiripentol can be increased when used in combination with Lofexidine.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be increased when combined with Stiripentol.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R06AX13, loratadine, The metabolism of Loratadine can be decreased when combined with Stiripentol.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Stiripentol is combined with Lormetazepam.]
[H01AA02, cosyntropin, The risk or severity of liver damage can be increased when Tetracosactide is combined with Stiripentol.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Stiripentol may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Manidipine can be decreased when combined with Stiripentol.]
[A03AA04, mebeverine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Medifoxamine.]
[S01BA08, medrysone, The metabolism of Medrysone can be decreased when combined with Stiripentol.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Stiripentol.]
[H02AB15, meprednisone, The metabolism of Meprednisone can be decreased when combined with Stiripentol.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Stiripentol.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R06AD04, methdilazine, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Methdilazine.]
[N04AA03, methixene, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[C04AX01, cyclandelate, The metabolism of Cyclandelate can be decreased when combined with Stiripentol.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Cyclizine is combined with Stiripentol.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Stiripentol is combined with Cyclobarbital.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Stiripentol.]
[N05AD03, metylperon, The metabolism of Melperone can be decreased when combined with Stiripentol.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA03, midecamycin, The metabolism of Midecamycin can be decreased when combined with Stiripentol.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Stiripentol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Stiripentol.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Minaprine is combined with Stiripentol.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Stiripentol.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Stiripentol.]
[N06BA07, modafinil, The metabolism of Modafinil can be decreased when combined with Stiripentol.]
[R06AX02, cyproheptadine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Stiripentol.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be decreased when combined with Stiripentol.]
[J05AF10, entecavir, The metabolism of Entecavir can be increased when combined with Stiripentol.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Stiripentol.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Stiripentol.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Stiripentol.]
[L01DA01, dactinomycin, The excretion of Dactinomycin can be decreased when combined with Stiripentol.]
[G03XA01, danazol, The metabolism of Stiripentol can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Dantrolene is combined with Stiripentol.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Stiripentol.]
[L01DB02, daunorubicin, The excretion of Daunorubicin can be decreased when combined with Stiripentol.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Stiripentol is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Stiripentol.]
[G03XX01, prasterone, The metabolism of Prasterone can be decreased when combined with Stiripentol.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Stiripentol.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be increased when combined with Stiripentol.]
[N07BB05, nalmefene, Nalmefene may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Stiripentol is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Stiripentol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Nefazodone can be decreased when combined with Stiripentol.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Niaprazine.]
[C01DX16, nicorandil, Stiripentol may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, The metabolism of Nilutamide can be decreased when combined with Stiripentol.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be decreased when combined with Stiripentol.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be decreased when combined with Stiripentol.]
[C01CA23, theodrenaline, Stiripentol may increase the excretion rate of Theodrenaline which could result in a lower serum level and potentially a reduction in efficacy.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Stiripentol.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Stiripentol is combined with Normethadone.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[D11AH02, pimecrolimus, The metabolism of Pimecrolimus can be decreased when combined with Stiripentol.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Stiripentol.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Stiripentol.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N06AA01, desipramine, The metabolism of Desipramine can be decreased when combined with Stiripentol.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01BA11, desonide, The metabolism of Desonide can be decreased when combined with Stiripentol.]
[V04CH02, indigo carmine, Stiripentol may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C09XA02, aliskiren, The metabolism of Aliskiren can be decreased when combined with Stiripentol.]
[L01XA03, oxaliplatin, The excretion of Oxaliplatin can be decreased when combined with Stiripentol.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Stiripentol.]
[S03BA01, dexamethasone, The metabolism of Dexamethasone can be decreased when combined with Stiripentol.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Stiripentol is combined with Oxiracetam.]
[N04AA08, dexetimide, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Stiripentol.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Stiripentol.]
[A03AA01, oxyphencyclimine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Stiripentol can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Stiripentol.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Stiripentol.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Stiripentol.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Stiripentol.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Dextromoramide is combined with Stiripentol.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Stiripentol.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Stiripentol.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Diamorphine is combined with Stiripentol.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C04AD01, pentifylline, Stiripentol may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Stiripentol.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Phenacemide is combined with Stiripentol.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Phenol.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Phensuximide is combined with Stiripentol.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Stiripentol is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Cinchocaine.]
[R05DA08, pholcodine, Stiripentol may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Stiripentol.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A03AA07, dicyclomine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C02DG01, pinacidil, The metabolism of Pinacidil can be decreased when combined with Stiripentol.]
[A03AX04, pinaverium, The metabolism of Pinaverium can be decreased when combined with Stiripentol.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be decreased when combined with Stiripentol.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Stiripentol is combined with Pipamperone.]
[A03AB14, pipenzolate, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Stiripentol.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Stiripentol.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Diethylpropion is combined with Stiripentol.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be decreased when combined with Stiripentol.]
[C08CA03, isradipine, The metabolism of Isradipine can be decreased when combined with Stiripentol.]
[D07XC04, diflucortolone, The metabolism of Difluocortolone can be decreased when combined with Stiripentol.]
[A03AB11, poldine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Stiripentol.]
[C01AA05, digoxin, The excretion of Digoxin can be decreased when combined with Stiripentol.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be increased when combined with Stiripentol.]
[C10AX09, ezetimibe, The excretion of Ezetimibe can be decreased when combined with Stiripentol.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Stiripentol.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Stiripentol.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Hydromorphone is combined with Stiripentol.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Atazanavir can be decreased when combined with Stiripentol.]
[B01AC21, treprostinil, The metabolism of Treprostinil can be decreased when combined with Stiripentol.]
[H03BC01, potassium perchlorate, Stiripentol may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Pramocaine.]
[D07AC18, prednicarbate, The metabolism of Prednicarbate can be decreased when combined with Stiripentol.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Stiripentol.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Stiripentol.]
[V03AB09, dimercaprol, Dimercaprol may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Stiripentol is combined with Pridinol.]
[R06AB03, dimethindene, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, The metabolism of Dimethyl sulfoxide can be decreased when combined with Stiripentol.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Progabide is combined with Stiripentol.]
[N06BC02, propentofylline, Stiripentol may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Proparacaine.]
[R03DA03, proxyphylline, Stiripentol may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Stiripentol.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Stiripentol.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Stiripentol.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Stiripentol.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Stiripentol.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Stiripentol.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Stiripentol.]
[S01AX06, resorcinol, Stiripentol may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The metabolism of Disopyramide can be decreased when combined with Stiripentol.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Stiripentol.]
[S02AA12, rifamycin SV, The metabolism of Stiripentol can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Rifapentine can be decreased when combined with Stiripentol.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Stiripentol.]
[N07XX02, riluzole, The excretion of Riluzole can be decreased when combined with Stiripentol.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Stiripentol.]
[R06AE09, levocetirizine, The metabolism of Levocetirizine can be decreased when combined with Stiripentol.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Stiripentol can be decreased when combined with Rosoxacin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Stiripentol.]
[A04AD12, aprepitant, The metabolism of Aprepitant can be decreased when combined with Stiripentol.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Stiripentol.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Stiripentol.]
[J05AE07, fosamprenavir, The metabolism of Fosamprenavir can be decreased when combined with Stiripentol.]
[G04BE08, tadalafil, The serum concentration of Tadalafil can be increased when it is combined with Stiripentol.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Stiripentol.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Stiripentol.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be decreased when combined with Stiripentol.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R03AC12, salmeterol, The metabolism of Salmeterol can be decreased when combined with Stiripentol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Stiripentol.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Stiripentol.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Stiripentol.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Stiripentol.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Stiripentol.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Stiripentol.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[A08AA10, sibutramine, The metabolism of Sibutramine can be decreased when combined with Stiripentol.]
[C10AA01, simvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Stiripentol is combined with Simvastatin.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, Stiripentol may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[G03DB01, dydrogesterone, The metabolism of Dydrogesterone can be decreased when combined with Stiripentol.]
[R03DA01, dyphylline, Stiripentol may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[D01AC09, sulconazole, The metabolism of Sulconazole can be decreased when combined with Stiripentol.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Stiripentol is combined with Sultopride.]
[N02CC01, sumatriptan, The excretion of Sumatriptan can be decreased when combined with Stiripentol.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C07AB13, talinolol, The excretion of Talinolol can be decreased when combined with Stiripentol.]
[H01AA01, corticotropin, The metabolism of Corticotropin can be decreased when combined with Stiripentol.]
[J01MA05, temafloxacin, The metabolism of Temafloxacin can be increased when combined with Stiripentol.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Stiripentol.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Stiripentol.]
[G04BD05, terodiline, The metabolism of Terodiline can be decreased when combined with Stiripentol.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Stiripentol.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Stiripentol resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Stiripentol is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Stiripentol is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Stiripentol is combined with Thiopropazate.]
[G04BD01, emepronium, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Stiripentol.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Tofisopam is combined with Stiripentol.]
[M01AG02, tolfenamic acid, The metabolism of Tolfenamic acid can be decreased when combined with Stiripentol.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Stiripentol is combined with Toloxatone.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Stiripentol.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Stiripentol.]
[L02BA02, toremifene, The metabolism of Toremifene can be decreased when combined with Stiripentol.]
[C03CA04, torsemide, The metabolism of Torasemide can be decreased when combined with Stiripentol.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Stiripentol is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Stiripentol.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Triclofos is combined with Stiripentol.]
[A03AB08, tridihexethyl, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[H02CA01, trilostane, The metabolism of Trilostane can be decreased when combined with Stiripentol.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Stiripentol.]
[N04AA12, tropatepine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Stiripentol.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Stiripentol is combined with Urapidil.]
[J01MA04, enoxacin, The metabolism of Stiripentol can be decreased when combined with Enoxacin.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Stiripentol is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Stiripentol.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Stiripentol.]
[N06AX16, venlafaxine, The metabolism of Venlafaxine can be decreased when combined with Stiripentol.]
[C08CA12, mepirodipine, The metabolism of Barnidipine can be decreased when combined with Stiripentol.]
[N05CF02, zolpidem, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, The metabolism of Zomepirac can be decreased when combined with Stiripentol.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Stiripentol.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Stiripentol.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Stiripentol.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C02AC02, guanfacine, The metabolism of Guanfacine can be decreased when combined with Stiripentol.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Moricizine is combined with Stiripentol.]
[G02AB03, ergonovine, The metabolism of Ergometrine can be decreased when combined with Stiripentol.]
[C04AE01, ergoloid mesylates, USP, The metabolism of Ergoloid mesylate can be decreased when combined with Stiripentol.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Stiripentol.]
[L03AX05, pidotimod, Stiripentol may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Erythromycin can be decreased when combined with Stiripentol.]
[N05CD04, estazolam, The metabolism of Estazolam can be decreased when combined with Stiripentol.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be decreased when combined with Stiripentol.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Stiripentol.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Stiripentol.]
[L01XX11, estramustine, The metabolism of Estramustine can be decreased when combined with Stiripentol.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Stiripentol.]
[J04AK02, ethambutol, The metabolism of Stiripentol can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Fluticasone furoate can be decreased when combined with Stiripentol.]
[R03BA05, fluticasone, The metabolism of Fluticasone can be decreased when combined with Stiripentol.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Stiripentol.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Stiripentol.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Stiripentol.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N04AA05, profenamine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The metabolism of Ethosuximide can be decreased when combined with Stiripentol.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Ethotoin is combined with Stiripentol.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Ethyl chloride.]
[M01AC06, meloxicam, The metabolism of Meloxicam can be decreased when combined with Stiripentol.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Stiripentol.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Etidocaine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Stiripentol.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Stiripentol.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Stiripentol.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Stiripentol.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Stiripentol.]
[R06AX12, terfenadine, The metabolism of Terfenadine can be decreased when combined with Stiripentol.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Stiripentol.]
[N06AB08, fluvoxamine, The metabolism of Fluvoxamine can be decreased when combined with Stiripentol.]
[C01BB03, tocainide, The metabolism of Tocainide can be increased when combined with Stiripentol.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Stiripentol.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Stiripentol.]
[M01CB01, gold sodium thiomalate, Stiripentol may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[A05AA01, chenodeoxycholic acid, The metabolism of Chenodeoxycholic acid can be decreased when combined with Stiripentol.]
[B05AA05, dextran, Stiripentol may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A02BA03, famotidine, The metabolism of Stiripentol can be decreased when combined with Famotidine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Stiripentol.]
[C08CA02, felodipine, The metabolism of Felodipine can be decreased when combined with Stiripentol.]
[C08EA01, fendiline, The metabolism of Fendiline can be decreased when combined with Stiripentol.]
[N03AX26, fenfluramine, The serum concentration of Fenfluramine can be increased when it is combined with Stiripentol.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Stiripentol.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Stiripentol.]
[L04AA40, cladribine, The excretion of Cladribine can be decreased when combined with Stiripentol.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Stiripentol.]
[G04BD02, flavoxate, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Stiripentol.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Stiripentol can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[H02AA02, fludrocortisone, The metabolism of Fludrocortisone can be decreased when combined with Stiripentol.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[D07XB01, flumethasone, The metabolism of Flumethasone can be decreased when combined with Stiripentol.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Stiripentol.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Stiripentol.]
[D07AC08, fluocinonide, The metabolism of Fluocinonide can be decreased when combined with Stiripentol.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Stiripentol is combined with Melitracen.]
[H02AB03, fluocortolone, The metabolism of Fluocortolone can be decreased when combined with Stiripentol.]
[V03AZ01, ethanol, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01CB05, fluorometholone, The metabolism of Fluorometholone can be decreased when combined with Stiripentol.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Stiripentol.]
[N06AB03, fluoxetine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[N05AF01, flupenthixol, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The metabolism of Fluphenazine can be decreased when combined with Stiripentol.]
[D07AC07, flurandrenolide, The metabolism of Flurandrenolide can be decreased when combined with Stiripentol.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be decreased when combined with Stiripentol.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Stiripentol.]
[N05AG01, fluspirilene, The metabolism of Fluspirilene can be decreased when combined with Stiripentol.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Stiripentol.]
[V04CX02, folic acid, The excretion of Folic acid can be decreased when combined with Stiripentol.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Stiripentol.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Stiripentol is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Furazolidone is combined with Stiripentol.]
[J05AE10, darunavir, The metabolism of Darunavir can be decreased when combined with Stiripentol.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Stiripentol is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Amisulpride is combined with Stiripentol.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Stiripentol.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Gallamine.]
[C08DA02, gallopamil, The metabolism of Gallopamil can be decreased when combined with Stiripentol.]
[S01AD09, ganciclovir, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Ganciclovir.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Barbexaclone is combined with Stiripentol.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Stiripentol is combined with Bifemelane.]
[C10AB04, gemfibrozil, The metabolism of Gemfibrozil can be decreased when combined with Stiripentol.]
[J01XA03, telavancin, Telavancin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Stiripentol.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Stiripentol.]
[C01CA21, cafedrine, Stiripentol may increase the excretion rate of Cafedrine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Stiripentol.]
[N03AD03, methsuximide, The metabolism of Methsuximide can be decreased when combined with Stiripentol.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be decreased when combined with Stiripentol.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Stiripentol.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Stiripentol.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Stiripentol.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Stiripentol.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Stiripentol.]
[N05CM18, dexmedetomidine, The metabolism of Dexmedetomidine can be decreased when combined with Stiripentol.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Glutethimide is combined with Stiripentol.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Stiripentol.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Stiripentol.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Stiripentol.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Stiripentol.]
[M01CB04, aurothioglucose, Stiripentol may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Stiripentol.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Stiripentol.]
[D07AD02, halcinonide, The metabolism of Halcinonide can be decreased when combined with Stiripentol.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Stiripentol.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Stiripentol.]
[N05AH04, quetiapine, The serum concentration of Quetiapine can be increased when it is combined with Stiripentol.]
[N06BX13, idebenone, Idebenone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Stiripentol is combined with Iprazochrome.]
[L01CE02, irinotecan, The serum concentration of SN-38, an active metabolite of Irinotecan, can be increased when used in combination with Stiripentol.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Stiripentol is combined with Allobarbital.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Stiripentol.]
[C09CA01, losartan, The metabolism of Losartan can be decreased when combined with Stiripentol.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Stiripentol.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Stiripentol.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Stiripentol.]
[C08CA10, nilvadipine, The metabolism of Nilvadipine can be decreased when combined with Stiripentol.]
[M02AA26, nimesulide, The metabolism of Nimesulide can be decreased when combined with Stiripentol.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C02DB02, hydralazine, Hydralazine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Stiripentol.]
[D07AC16, hydrocortisone aceponate, The metabolism of Hydrocortisone aceponate can be decreased when combined with Stiripentol.]
[D07AB11, hydrocortisone probutate, The metabolism of Hydrocortisone probutate can be decreased when combined with Stiripentol.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Stiripentol may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[G04BD06, propiverine, The metabolism of Propiverine can be decreased when combined with Stiripentol.]
[P01BA02, hydroxychloroquine, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Stiripentol is combined with Prothipendyl.]
[B05AA07, hetastarch, Hydroxyethyl Starch may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[G03DA03, 17-alpha-hydroxyprogesterone, The metabolism of Hydroxyprogesterone can be decreased when combined with Stiripentol.]
[L01XX05, hydroxyurea, The metabolism of Hydroxyurea can be decreased when combined with Stiripentol.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[J04AB04, rifabutin, The metabolism of Rifabutin can be decreased when combined with Stiripentol.]
[S01BA13, rimexolone, The metabolism of Rimexolone can be decreased when combined with Stiripentol.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Stiripentol.]
[B05XA08, sodium acetate, Stiripentol may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Stiripentol.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Stiripentol.]
[H01AC02, somatrem, The metabolism of Stiripentol can be increased when combined with Somatrem.]
[N01AH03, sufentanil, The metabolism of Sufentanil can be decreased when combined with Stiripentol.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Stiripentol.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Stiripentol.]
[R01AD07, tixocortol, Tixocortol may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M03BX02, tizanidine, The metabolism of Tizanidine can be decreased when combined with Stiripentol.]
[L01CE01, topotecan, The excretion of Topotecan can be decreased when combined with Stiripentol.]
[C03BA11, indapamide, The metabolism of Indapamide can be decreased when combined with Stiripentol.]
[S01BC01, indomethacin, The metabolism of Indomethacin can be decreased when combined with Stiripentol.]
[A11HA07, inositol, Stiripentol may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The metabolism of Stiripentol can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Stiripentol can be decreased when combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be decreased when combined with Stiripentol.]
[A03AA30, piperidolate, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Articaine.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Stiripentol.]
[V08AB02, iohexol, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Iohexol.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Stiripentol.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Stiripentol.]
[R06AE01, buclizine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be decreased when combined with Stiripentol.]
[L01XX35, anagrelide, The metabolism of Anagrelide can be decreased when combined with Stiripentol.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Alprenolol is combined with Stiripentol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The metabolism of Stiripentol can be decreased when combined with Interferon alfacon-1.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Stiripentol.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Stiripentol is combined with Iprindole.]
[N06AF05, iproniazid, The metabolism of Iproniazid can be decreased when combined with Stiripentol.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be increased when combined with Stiripentol.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Chlorproethazine.]
[D06BB10, imiquimod, The metabolism of Imiquimod can be decreased when combined with Stiripentol.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Stiripentol.]
[P01AX06, atovaquone, The metabolism of Atovaquone can be decreased when combined with Stiripentol.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Stiripentol.]
[N04BX02, entacapone, The metabolism of Entacapone can be decreased when combined with Stiripentol.]
[J04AC01, isoniazid, The metabolism of Isoniazid can be decreased when combined with Stiripentol.]
[J05AX05, inosine pranobex, Stiripentol may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[D10BA01, isotretinoin, The metabolism of Isotretinoin can be decreased when combined with Stiripentol.]
[P02CF01, ivermectin, The metabolism of Ivermectin can be decreased when combined with Stiripentol.]
[N06AX18, reboxetine, The metabolism of Reboxetine can be decreased when combined with Stiripentol.]
[S01AA24, kanamycin, Stiripentol may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The metabolism of Stiripentol can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Stiripentol can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Stiripentol.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Stiripentol is combined with Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Stiripentol.]
[J02AB02, ketoconazole, The metabolism of Ketoconazole can be decreased when combined with Stiripentol.]
[H02CA04, levoketoconazole, The metabolism of Levoketoconazole can be decreased when combined with Stiripentol.]
[N05AH03, olanzapine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[V03AC03, deferasirox, The serum concentration of Stiripentol can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Stiripentol can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Stiripentol.]
[J01MB02, nalidixic acid, The metabolism of Stiripentol can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[D11AX02, gamma-linolenic acid, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Gamolenic acid.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Stiripentol.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J05AX09, maraviroc, The metabolism of Maraviroc can be decreased when combined with Stiripentol.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Stiripentol.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[R05CB06, ambroxol, The metabolism of Ambroxol can be decreased when combined with Stiripentol.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be decreased when combined with Stiripentol.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Levodopa is combined with Stiripentol.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Stiripentol.]
[C08EX01, lidoflazine, The metabolism of Lidoflazine can be decreased when combined with Stiripentol.]
[S01AA21, amikacin, Stiripentol may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Stiripentol can be decreased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Stiripentol.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Stiripentol.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Lofepramine.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Stiripentol.]
[N05BA06, lorazepam, The metabolism of Lorazepam can be decreased when combined with Stiripentol.]
[C10AA02, lovastatin, The serum concentration of Lovastatin can be increased when it is combined with Stiripentol.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Loxapine is combined with Stiripentol.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Stiripentol.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Stiripentol.]
[B05XA11, magnesium chloride, Stiripentol may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Stiripentol can be increased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, The excretion of Pralatrexate can be decreased when combined with Stiripentol.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Stiripentol.]
[V04CX04, mannitol, The excretion of Mannitol can be decreased when combined with Stiripentol.]
[N06AA21, maprotiline, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Stiripentol.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Meclizine is combined with Stiripentol.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Stiripentol is combined with Medazepam.]
[C01AA08, medigoxin, Stiripentol may decrease the excretion rate of Metildigoxin which could result in a higher serum level.]
[G03DB03, medrogestone, The metabolism of Medrogestone can be decreased when combined with Stiripentol.]
[P01BC02, mefloquine, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Mefloquine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Melatonin is combined with Stiripentol.]
[N06DX01, memantine, The metabolism of Stiripentol can be decreased when combined with Memantine.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Stiripentol.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Stiripentol.]
[N03AA01, mephobarbital, The serum concentration of Stiripentol can be decreased when it is combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Stiripentol.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Stiripentol is combined with Meptazinol.]
[G04BX16, tiopronin, Tiopronin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Mesoridazine is combined with Stiripentol.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Stiripentol.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Stiripentol.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Stiripentol.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Metamfetamine is combined with Stiripentol.]
[A03AB07, methantheline, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Methapyrilene is combined with Stiripentol.]
[N05CM01, methaqualone, The metabolism of Methaqualone can be decreased when combined with Stiripentol.]
[J05AF05, lamivudine, The excretion of Lamivudine can be decreased when combined with Stiripentol.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Stiripentol.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, The serum concentration of Metergoline can be increased when it is combined with Stiripentol.]
[H03BB02, methimazole, The metabolism of Methimazole can be decreased when combined with Stiripentol.]
[L01BA04, pemetrexed, Stiripentol may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Stiripentol.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Methohexital is combined with Stiripentol.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Stiripentol is combined with Ziconotide.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Stiripentol.]
[N05AA02, methotrimeprazine, The metabolism of Methotrimeprazine can be decreased when combined with Stiripentol.]
[D05BA02, methoxsalen, The metabolism of Stiripentol can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Stiripentol.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be decreased when combined with Stiripentol.]
[G02AB01, methylergonovine, The metabolism of Methylergometrine can be decreased when combined with Stiripentol.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Stiripentol.]
[N06BA04, methylphenidate, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Methylphenidate.]
[H02AB04, methylprednisolone, The metabolism of Methylprednisolone can be decreased when combined with Stiripentol.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Stiripentol.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Stiripentol.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Methyprylon is combined with Stiripentol.]
[N02CA04, methysergide, The metabolism of Methysergide can be decreased when combined with Stiripentol.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Stiripentol.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The metabolism of Metoprolol can be decreased when combined with Stiripentol.]
[P01AB01, metronidazole, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Metronidazole.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Stiripentol.]
[N06AX03, mianserin, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Mianserin.]
[S02AA13, miconazole, The metabolism of Miconazole can be decreased when combined with Stiripentol.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Stiripentol.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Stiripentol.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be decreased when combined with Stiripentol.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C09CA03, valsartan, The metabolism of Valsartan can be decreased when combined with Stiripentol.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[L01XX23, mitotane, The metabolism of Stiripentol can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The excretion of Mitoxantrone can be decreased when combined with Stiripentol.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Stiripentol.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Molindone is combined with Stiripentol.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be decreased when combined with Stiripentol.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Stiripentol.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Stiripentol.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Stiripentol.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Stiripentol can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Stiripentol.]
[G04BA01, ammonium chloride, Ammonium chloride may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Stiripentol.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Vecuronium is combined with Stiripentol.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Amobarbital is combined with Stiripentol.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Stiripentol.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Stiripentol.]
[G03XC01, raloxifene, The excretion of Raloxifene can be decreased when combined with Stiripentol.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Stiripentol.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Stiripentol.]
[L03AB08, interferon beta-1b, The metabolism of Stiripentol can be decreased when combined with Interferon beta-1b.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Stiripentol.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N04BC04, ropinirole, The metabolism of Ropinirole can be increased when combined with Stiripentol.]
[J01CF06, nafcillin, The metabolism of Stiripentol can be increased when combined with Nafcillin.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Stiripentol is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Nalbuphine is combined with Stiripentol.]
[V03AB15, naloxone, The metabolism of Stiripentol can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Stiripentol can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Stiripentol.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Stiripentol.]
[A10BG01, troglitazone, The metabolism of Troglitazone can be decreased when combined with Stiripentol.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Stiripentol.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Stiripentol.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Stiripentol.]
[L02BG04, letrozole, The metabolism of Letrozole can be decreased when combined with Stiripentol.]
[S03AA01, neomycin, Stiripentol may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Remifentanil is combined with Stiripentol.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Stiripentol.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Stiripentol.]
[J02AA01, amphotericin B, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Amphotericin B.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L03AX16, plerixafor, Plerixafor may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01AA23, netilmicin, Stiripentol may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Desvenlafaxine can be decreased when combined with Stiripentol.]
[C09CA07, telmisartan, The metabolism of Stiripentol can be decreased when combined with Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[H05BX02, paricalcitol, The metabolism of Paricalcitol can be decreased when combined with Stiripentol.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C10AD02, niacin, The metabolism of Niacin can be decreased when combined with Stiripentol.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Nialamide is combined with Stiripentol.]
[C08CA04, nicardipine, The metabolism of Nicardipine can be decreased when combined with Stiripentol.]
[C04AE02, nicergoline, The serum concentration of Nicergoline can be increased when it is combined with Stiripentol.]
[P02DA01, niclosamide, The metabolism of Stiripentol can be decreased when combined with Niclosamide.]
[N07BA01, nicotine, The metabolism of Nicotine can be decreased when combined with Stiripentol.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Stiripentol.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C08CA06, nimodipine, The metabolism of Nimodipine can be decreased when combined with Stiripentol.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be decreased when combined with Stiripentol.]
[N05CD02, nitrazepam, The metabolism of Nitrazepam can be decreased when combined with Stiripentol.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be decreased when combined with Stiripentol.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01XE01, nitrofurantoin, The excretion of Nitrofurantoin can be decreased when combined with Stiripentol.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Stiripentol.]
[N04BC05, pramipexole, Stiripentol may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Stiripentol.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Nomifensine is combined with Stiripentol.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Stiripentol.]
[S01AE02, norfloxacin, The metabolism of Stiripentol can be decreased when combined with Norfloxacin.]
[G03AC07, norgestrienone, The metabolism of Norgestrienone can be increased when combined with Stiripentol.]
[C02KX01, bosentan, The metabolism of Bosentan can be decreased when combined with Stiripentol.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Stiripentol.]
[L03AB07, interferon beta-1a, The metabolism of Stiripentol can be decreased when combined with Interferon beta-1a.]
[G02CA02, nylidrin, The metabolism of Nylidrin can be decreased when combined with Stiripentol.]
[L04AC04, rilonacept, The metabolism of Stiripentol can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Stiripentol.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Stiripentol is combined with Opipramol.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Stiripentol.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Stiripentol.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[P02BA02, oxamniquine, The metabolism of Oxamniquine can be decreased when combined with Stiripentol.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Oxazepam is combined with Stiripentol.]
[C07AA02, oxprenolol, The metabolism of Oxprenolol can be decreased when combined with Stiripentol.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Stiripentol.]
[A14AA05, oxymetholone, The metabolism of Oxymetholone can be decreased when combined with Stiripentol.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Stiripentol.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A03AB03, oxyphenonium, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The metabolism of Asenapine can be decreased when combined with Stiripentol.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[M03AC01, pancuronium, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[J04AB30, capreomycin, Stiripentol may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be decreased when combined with Stiripentol.]
[N05CC05, paraldehyde, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The metabolism of Paramethasone can be decreased when combined with Stiripentol.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Pargyline is combined with Stiripentol.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01MA03, pefloxacin, The metabolism of Stiripentol can be decreased when combined with Pefloxacin.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Stiripentol.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Penbutolol is combined with Stiripentol.]
[N05AG03, penfluridol, The metabolism of Penfluridol can be decreased when combined with Stiripentol.]
[J01CE09, penicillin G procaine, Stiripentol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Pentazocine is combined with Stiripentol.]
[N05CA01, pentobarbital, The metabolism of Stiripentol can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Stiripentol may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Stiripentol may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Perazine.]
[N04BC02, pergolide, The serum concentration of Pergolide can be increased when it is combined with Stiripentol.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Stiripentol.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Stiripentol.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Stiripentol.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Phenazocine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[N06AF03, phenelzine, The metabolism of Phenelzine can be decreased when combined with Stiripentol.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Stiripentol.]
[N03AA02, phenobarbital, The serum concentration of Stiripentol can be decreased when it is combined with Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Stiripentol is combined with Phenoperidine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Stiripentol.]
[A08AA01, phentermine, The metabolism of Phentermine can be decreased when combined with Stiripentol.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[M02AA01, phenylbutazone, The metabolism of Phenylbutazone can be decreased when combined with Stiripentol.]
[S01GA05, phenylephrine, The metabolism of Stiripentol can be increased when combined with Phenylephrine.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be decreased when combined with Stiripentol.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be increased when it is combined with Stiripentol.]
[L04AB06, golimumab, The metabolism of Stiripentol can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Stiripentol.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C08CX01, mibefradil, The metabolism of Mibefradil can be decreased when combined with Stiripentol.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Stiripentol.]
[C07AA03, pindolol, The metabolism of Pindolol can be decreased when combined with Stiripentol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Stiripentol.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Saquinavir can be decreased when combined with Stiripentol.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Stiripentol.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Stiripentol.]
[N06BX03, piracetam, Stiripentol may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[A02BX03, pirenzepine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Stiripentol is combined with Piritramide.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Stiripentol.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be decreased when combined with Stiripentol.]
[N02CX01, pizotyline, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Delavirdine can be decreased when combined with Stiripentol.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Stiripentol.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Stiripentol is combined with Proxibarbal.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Stiripentol.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be decreased when combined with Stiripentol.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Stiripentol.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Stiripentol.]
[L04AC08, canakinumab, The metabolism of Stiripentol can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Stiripentol can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Stiripentol.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Stiripentol.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Stiripentol.]
[N05BA11, prazepam, The metabolism of Prazepam can be decreased when combined with Stiripentol.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Stiripentol.]
[C02CA01, prazosin, The excretion of Prazosin can be decreased when combined with Stiripentol.]
[S03BA02, prednisolone, The metabolism of Prednisolone can be decreased when combined with Stiripentol.]
[H02AB07, prednisone, The metabolism of Prednisone can be decreased when combined with Stiripentol.]
[C01DX02, prenylamine, The metabolism of Prenylamine can be decreased when combined with Stiripentol.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Primaquine can be decreased when combined with Stiripentol.]
[N03AA03, primidone, The serum concentration of Stiripentol can be decreased when it is combined with Primidone.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Stiripentol.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Procarbazine is combined with Stiripentol.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Stiripentol.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Stiripentol.]
[N04AA04, procyclidine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Stiripentol.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Stiripentol.]
[G03DB07, promegestone, The metabolism of Promegestone can be decreased when combined with Stiripentol.]
[R06AD02, promethazine, The metabolism of Promethazine can be decreased when combined with Stiripentol.]
[C01BC03, propafenone, The metabolism of Propafenone can be decreased when combined with Stiripentol.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Stiripentol is combined with Propanidid.]
[A03AB05, propantheline, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Stiripentol.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Periciazine is combined with Stiripentol.]
[N05CM06, propiomazine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Stiripentol.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Stiripentol.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be decreased when combined with Stiripentol.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Stiripentol.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Rizatriptan is combined with Stiripentol.]
[B01AC09, epoprostenol, Epoprostenol may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Stiripentol.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Protriptyline is combined with Stiripentol.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Stiripentol.]
[N07XX07, dalfampridine, Dalfampridine may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A03AB15, diphemanil, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Stiripentol.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Stiripentol is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Captodiame is combined with Stiripentol.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Stiripentol is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Stiripentol is combined with Pyrantel.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R06AC01, pyrilamine, The metabolism of Mepyramine can be decreased when combined with Stiripentol.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Stiripentol.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Stiripentol.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Stiripentol.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Stiripentol.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Stiripentol.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Stiripentol can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Oxitriptan is combined with Stiripentol.]
[J01FA06, roxithromycin, The metabolism of Roxithromycin can be decreased when combined with Stiripentol.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[A07EC01, sulfasalazine, The excretion of Sulfasalazine can be decreased when combined with Stiripentol.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Stiripentol.]
[S01FA02, scopolamine, The metabolism of Scopolamine can be decreased when combined with Stiripentol.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Secobarbital is combined with Stiripentol.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Stiripentol.]
[J01GB08, sisomicin, Stiripentol may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Stiripentol may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Stiripentol.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Stiripentol.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Stiripentol.]
[V09AB03, ioflupane I-123, Ioflupane I-123 may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Stiripentol may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09GA01, technetium Tc 99m sestamibi, The excretion of Technetium Tc-99m sestamibi can be decreased when combined with Stiripentol.]
[V09AX06, florbetaben f-18, Stiripentol may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be decreased when combined with Stiripentol.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Stiripentol.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[R03BB01, ipratropium bromide, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
